Phytel Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Phytel Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013343
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phytel Inc (Phytel), a subsidiary of International Business Machines Corporation is an integrated population health management software and solutions provider. The company’s services include reduce total cost of care, prepare for value based care, increase patient engagement, measure quality and outcomes, scale care management, improve patient satisfaction, reduce avoidable readmissions, PCMH qualify, medicare risk management, and IT investment maximization services. It also provides population health technology, clinical evidence, evidence-based chronic and preventive care protocols, scale care management, and LED population health management solutions. Phytel offers data aggregation, care coordination, risk stratification, transition, and value based care solutions. The company serves accountable care organizations, hospitals, physician practices, integrated delivery networks, health systems, community health centers, and consultants. Phytel is headquartered in Dallas, Texas, the US.

Phytel Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phytel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phytel Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phytel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phytel Inc, Medical Devices Deals, 2011 to YTD 2017 8
Phytel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phytel Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Phytel Raises US$5 Million In Venture Financing 10
Phytel Raises Additional US$1.3 Million In Series F Financing 11
Partnerships 12
Phytel Enters Into Technology Integration Agreement With BerylHealth 12
Phytel Inc – Key Competitors 13
Phytel Inc – Key Employees 14
Phytel Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Phytel Inc, Pharmaceuticals & Healthcare, Key Facts 2
Phytel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Phytel Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phytel Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phytel Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phytel Inc, Medical Devices Deals, 2011 to YTD 2017 8
Phytel Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phytel Raises US$5 Million In Venture Financing 10
Phytel Raises Additional US$1.3 Million In Series F Financing 11
Phytel Enters Into Technology Integration Agreement With BerylHealth 12
Phytel Inc, Key Competitors 13
Phytel Inc, Key Employees 14

★海外企業調査レポート[Phytel Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Futuren (FTRN):企業の財務・戦略的SWOT分析
    Futuren (FTRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Army and Air Force Exchange Service:戦略・SWOT・企業財務分析
    Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report Summary Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Underwriters Laboratories Inc.:企業のM&A・事業提携・投資動向
    Underwriters Laboratories Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Underwriters Laboratories Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Babcock & Wilcox Enterprises Inc (BW):企業の財務・戦略的SWOT分析
    Babcock & Wilcox Enterprises Inc (BW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • SOM Biotech SL:製薬・医療:M&Aディール及び事業提携情報
    Summary SOM Biotech SL (SOM Biotech) is a drug repurposing company that discovers and develops new drugs for orphan indications. The company’s pipeline products include SOM0777, SOM0226, SOM3355, SOM1201 and SOM2201 are used for the treatment of TTR amyloidosis, glioblastoma, huntington disease, duc …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Toa Corp (1885):企業の財務・戦略的SWOT分析
    Toa Corp (1885) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Luna Innovations Inc (LUNA):企業の財務・戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析
    Summary Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devi …
  • Dubai Electricity and Water Authority-エネルギー分野:企業M&A・提携分析
    Summary Dubai Electricity and Water Authority (DEWA) generates, transmits and distributes electricity; and conducts desalination of water. DEWA’s power plants included Jebel Ali Power Station D, E, G, K, L Phase I, L Phase II, and M; Aweer Power Station H Phase I, Phase II, and Phase III. The desali …
  • OHB System AG:企業の戦略・SWOT・財務情報
    OHB System AG - Strategy, SWOT and Corporate Finance Report Summary OHB System AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Hayleys PLC (HAYL.N0000):企業の財務・戦略的SWOT分析
    Summary Hayleys plc (Hayleys) is a diversified company that offers consumer services. The company’s products include purification products, textiles and construction materials, among others. It offers services such as treasury unit, strategic business development unit, corporate communications, corp …
  • Barnes & Noble, Inc.:企業の戦略・SWOT・財務情報
    Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Renesas Electronics Corp (6723):企業の財務・戦略的SWOT分析
    Renesas Electronics Corp (6723) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • GlycoNex Inc (4168):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoNex Inc (GlycoNex) is a drug discovery company that conducts research and development in glycosphingolipid antigen and human monoclonal antibody technologies to develop cancer drugs. The company carries out antibody drug development through its various technology platforms such as glyco …
  • TriVascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • Piller Group GmbH:企業の戦略的SWOT分析
    Piller Group GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆